Skip to main content
Premium Trial:

Request an Annual Quote

Steve McPhail

Fluidigm has hired Steve McPhail as general manager of the company's production genomics business. McPhail joins Fluidigm from Quintiles Transnational, where he served as president of the worldwide genomics business. He also previously served as president and CEO of Expression Analysis prior to its acquisition by Quintiles. McPhail has also held senior management positions at Argomed, Xanthon, TriPath Imaging, Dynex Technologies, and Abbott Laboratories.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.